Project Grant IL54983BIL

This Project Grant from the National Heart, Lung and Blood Institute, part of the Department of Health and Human Services, was awarded under the Cardiovascular Diseases Research program (CFDA 93.837) to develop clinical software to support quantitative analysis and interpretation of myocardial contrast echocardiography (MCE) data. Narnar, LLC received $757,197 to create software modules that enhance MCE's ability to identify coronary microvascular dysfunction (MVD). The software will average...

The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), was awarded a $161,169 Project Grant by the Office of the Director at the National Institutes of Health under the Research Infrastructure Programs (CFDA 93.351) to purchase a state-of-the-art metabolic/gas exchange system compatible with magnetic resonance imaging (MRI). This specialized equipment will enable a wide range of breath-by-breath gas exchange and pulmonary function measurements as well as...

This Project Grant award from the National Institutes of Health (NIH) Office of Research Infrastructure Programs (CFDA 93.351) provides $481,800 to East Tennessee State University (ETSU) to acquire a Vevo F2 ultrasound imaging system. The award date is May 1, 2025, with a planned completion date of April 30, 2026. The Vevo F2 system will replace ETSU's aging Vevo 1100 ultrasound imager, which is no longer supported by the manufacturer. The new system will support cardiovascular and cancer...

The U.S. Department of Health and Human Services, through the Congressional Directives program (CFDA 93.493), awarded a $650,000 Project Grant to Guadalupe County Hospital, a rural emergency hospital in Santa Rosa, New Mexico. The grant, awarded on September 30, 2024, will fund the upgrade of the hospital's radiology department, including the replacement of obsolete equipment and unsupported technology. Specifically, the project will install a new 128 CT scanner, a fully digital X-ray suite with...

This Project Grant award from the National Heart Lung and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) provides $585,794 to Tele-Stethoscope Inc., a self-certified small disadvantaged business, to develop a novel mobile phone technology that can detect preeclampsia and hypertension. The key products to be delivered under this award include: Proof-of-concept demonstration that ordinary mobile phones can accurately reproduce a physician's diagnosis of preeclampsia....

This $564,650 Project Grant awarded by the National Institutes of Health (NIH) Office of Research Infrastructure Programs (CFDA 93.351) supports the University of Louisville's acquisition of a Visualsonics Vevo F2 preclinical ultrasound system. This instrumentation will expand the capacity of the university's Physiology Core to meet the growing ultrasound imaging needs of over 30 investigators across five NIH-funded centers conducting research in cardiovascular health, cancer, hepatic and...

This Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) provides $1,107,276 to Lasarrus Clinic And Research Center Inc. to develop a mobile health system for remote monitoring of patients with Chronic Obstructive Pulmonary Disease (COPD). The project aims to enhance patient adherence to remote monitoring and early symptom recognition, in order to reduce COPD readmissions and healthcare costs. The system utilizes a wearable...

This Project Grant award from the National Heart Lung and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) aims to develop a modern Electrical Impedance Tomography (EIT) device for monitoring children in the Intensive Care Unit (ICU). The $299,900 award to Goodlife Inventors LLC will fund efforts to (1) generate initial designs for an advanced lightweight EIT belt and (2) assess the technical feasibility of a miniaturized, easier to use EIT core device. If...

This Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) provides $500,000 in funding to Aventusoft LLC, a small business located in Boca Raton, FL. The goal of this late-stage development project is to advance Aventusoft's non-invasive "HATS-OFF" heart failure monitoring technology towards commercialization. Specifically, the award will enable Aventusoft to: 1) Manufacture the HATS-OFF device with added ECG...

This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $777,674 to The General Hospital Corporation (doing business as Massachusetts General Hospital) to build the largest echocardiography registry in the world and apply advanced causal inference methods to measure the effects of guideline-directed medical therapies on mortality in patients with heart failure and mid-range ejection...